These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9818542)

  • 41. Disease models of autoimmunity.
    Ferguson CA
    Trends Immunol; 2005 Nov; 26(11):557-8. PubMed ID: 16182605
    [No Abstract]   [Full Text] [Related]  

  • 42. Interferons, a group of multiple lymphokines.
    Kirchner H
    Springer Semin Immunopathol; 1984; 7(4):347-74. PubMed ID: 6084313
    [No Abstract]   [Full Text] [Related]  

  • 43. Autoantibodies against PDGF receptor in scleroderma.
    Tan FK
    N Engl J Med; 2006 Jun; 354(25):2709-11. PubMed ID: 16790706
    [No Abstract]   [Full Text] [Related]  

  • 44. [Disorders of cellular immunity in systemic scleroderma].
    Sierakowski SJ; Kucharz EJ
    Przegl Lek; 1988; 45(7):592-7. PubMed ID: 3070641
    [No Abstract]   [Full Text] [Related]  

  • 45. [Autoimmune diseases].
    Deuel W; Siegenthaler-Zuber G; Siegenthaler W
    Schweiz Rundsch Med Prax; 1988 May; 77(18):485-8. PubMed ID: 3051259
    [No Abstract]   [Full Text] [Related]  

  • 46. [Masking of pan-T-cell markers in patients with autoimmune diseases].
    Grunow R; Volk HD; Schwaab J; Barthelmes H; Lande L; von Baehr R
    Dermatol Monatsschr; 1987; 173(7):390-9. PubMed ID: 3498654
    [No Abstract]   [Full Text] [Related]  

  • 47. [Clinical study of autoimmune diseases: recent trends--with special reference to progress in immunological tests and therapeutic methods. Systemic autoimmune diseases. 2) Systemic scleroderma and polymyositis].
    Kinoshita M; Yokohari R
    Nihon Rinsho; 1988 Apr; 46(4):873-8. PubMed ID: 3261361
    [No Abstract]   [Full Text] [Related]  

  • 48. [Demonstration of antinuclear antibodies in the epidermis of patients with progressive systemic sclerosis, generalized lupus erythematosus and dermatomyositis].
    Lamas Robles C; Mejía Arreguín S; Orozco Medina JH; González Mendoza A
    Rev Invest Clin; 1984; 36(2):115-9. PubMed ID: 6385174
    [No Abstract]   [Full Text] [Related]  

  • 49. Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis.
    Baroni SS; Santillo M; Bevilacqua F; Luchetti M; Spadoni T; Mancini M; Fraticelli P; Sambo P; Funaro A; Kazlauskas A; Avvedimento EV; Gabrielli A
    N Engl J Med; 2006 Jun; 354(25):2667-76. PubMed ID: 16790699
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Progressive systemic sclerosis. Chromosomal instability nd its correlation with the presence of autoantibodies].
    Martínez-Cordero E; Reyes López PA; Vergara MD; Morán Ramón L; Benavides de Larraza G; Kofman de Alfaro S; Katona Salgo G
    Rev Invest Clin; 1985; 37(4):329-35. PubMed ID: 3879371
    [No Abstract]   [Full Text] [Related]  

  • 51. [Lymphocytotoxic antibodies in autoimmune diseases].
    Klingelhöfer HL; Malchow H; Havemann K; Börngen U
    Verh Dtsch Ges Inn Med; 1972; 78():884-7. PubMed ID: 4665773
    [No Abstract]   [Full Text] [Related]  

  • 52. The autoimmune diseases.
    Condemi JJ
    JAMA; 1987 Nov; 258(20):2920-9. PubMed ID: 3312676
    [No Abstract]   [Full Text] [Related]  

  • 53. Anti-endothelial cell antibodies in systemic sclerosis.
    Mihai C; Tervaert JW
    Ann Rheum Dis; 2010 Feb; 69(2):319-24. PubMed ID: 20107031
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ABC of dermatology. Autoimmunity and skin disease.
    Gawkrodger DJ
    Br Med J (Clin Res Ed); 1987 Dec; 295(6611):1471-4. PubMed ID: 3121065
    [No Abstract]   [Full Text] [Related]  

  • 55. [Anti-viral treatment: pro or cons type I IFN?].
    Whitehead P; Drouet B; Zagury D; Bensussan A
    Med Sci (Paris); 2013 Oct; 29(10):836-9. PubMed ID: 24148119
    [No Abstract]   [Full Text] [Related]  

  • 56. Reflux and autoimmunity: common links among patients with pulmonary fibrosis?
    Fischer A; Meehan R; Brown K; Feghali-Bostwick C; West S
    Chest; 2007 Mar; 131(3):940-941. PubMed ID: 17356120
    [No Abstract]   [Full Text] [Related]  

  • 57. [Demonstration of antinuclear factors using indirect immunofluorescence in scleroderma patients].
    Nebe H; Blume N
    Dermatol Monatsschr; 1971 Jan; 157(1):27-31. PubMed ID: 4938251
    [No Abstract]   [Full Text] [Related]  

  • 58. Autoimmune disorders: nail signs and therapeutic approaches.
    Sherber NS; Wigley FM; Scher RK
    Dermatol Ther; 2007; 20(1):17-30. PubMed ID: 17403257
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The rationale behind autologous autoimmune hematopoietic stem cell transplant conditioning regimens: concerns over the use of total-body irradiation in systemic sclerosis.
    Burt RK; Patel D; Thomas J; Yeager A; Traynor A; Heipe F; Arnold R; Marmont A; Collier D; Glatstein E; Snowden J
    Bone Marrow Transplant; 2004 Nov; 34(9):745-51. PubMed ID: 15361910
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Limbic encephalitis associated with systemic sclerosis.
    De Stefano P; Chizzolini C; Lalive PH; Lascano AM
    Mult Scler Relat Disord; 2018 Aug; 24():142-144. PubMed ID: 30005357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.